Skip to main content

Mast Erle T's Form 4 filing

Zogenix, Inc. (ZGNX) · filed Jan 21, 2022

Accession no.
0001375151-22-000002
Filed
Jan 21, 2022
Trade date
Jan 19, 2022
Filing delay
2 days
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $391.4K. It was filed 2 days after the trade.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Mast Erle TCIK 0001051411Director

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Jan 19, 2022Stock Option (Right to Buy)MOption exerciseAcquired+6,250$15.04+$94,0009,277Direct
Jan 19, 2022Stock Option (Right to Buy)MOption exerciseAcquired+4,375$14.88+$65,10013,652Direct
Jan 19, 2022Stock Option (Right to Buy)MOption exerciseAcquired+4,375$12.00+$52,50018,027Direct
Jan 19, 2022Stock Option (Right to Buy)SSaleDisposed−15,000$26.09F2−$391,3503,027Direct

Derivative securities (Table II)

Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.

Derivative transactions
Trade dateSecurityTransactionUnderlying sharesUnit priceValueHeld afterOwnershipFlags
Jan 19, 2022Common StockMOption exerciseDisposed−6,250$0.00$00Direct
Jan 19, 2022Common StockMOption exerciseDisposed−4,375$0.00$00Direct
Jan 19, 2022Common StockMOption exerciseDisposed−4,375$0.00$01,250Direct

Footnotes and remarks

Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.

F2

Represents the weighted average sales price per share. The shares were sold at prices ranging from $26.05 to $26.15 per share. Full information regarding the number of shares sold at each price shall be provided upon request to the Staff of the U.S. Securities and Exchange Commission, the Issuer, or a security holder of the Issuer.

Referenced by the price of 1 transaction in Table I.

Read the full filing on SEC EDGAR (opens in a new tab)